Plethico Pharma to Take Over 20% stake in Tricon Holdings arm for $20 mn

A global pharma company with a strong emphasis on herbal and neutralceutical segments, Plethico Pharmaceuticals Ltd, is all set to acquire 20% stake in the Sputnik Regional Aptika Holdings Ltd, a drug retailer in the Commonwealth of Independent States, or CIS, from Hong Kong-based Tricon Holdings Ltd for $20 million (Rs100 crore).

Novartis, a leading Switzerland based multinational pharma company, has informed that it has linked up with USV, a leading healthcare company to sell its anti- diabetic product Galvus in India.

According to the sources, the tie up with USV is a part of Novartis plans to pitch its proposed product against Merck's Januvia by pricing it lower - in the Indian anti-diabetic market which saw total sales of Rs 1,672 crore till June 2008.

Glenmark Generics Ltd's US subsidiary (GGI) has notified that the company has started distribution of Morphine Sulfate Oral Concentrate Solution in the U.S. market through a licensing pact with a U.S. based pharmaceutical development company. 

The latest introduction will be the fifth product offered by Glenmark in the segment of pain management.

The company will market Morphine Sulfate Oral Concentrate Solution in three presentations, which is indicative for the relief of severe acute and severe chronic pain.

Glenmark Generics Ltd, a division of drug maker Glenmark Pharmaceuticals Ltd, has made announcement about the launching of its anti-hypertension drug ‘Perindopril’ in the UK market.

Lawyers for drug maker Wyeth and the Bush administration told the U.S. Supreme Court that according to a federal law pharmaceutical companies are not liable for harm from medicines that meet the standards set by the Food and Drug Administration and used as the label indicates.